Pioneering treatment aims to protect babies from devastating virus before birth
NCT ID NCT01651585
Summary
This study tested whether giving the antiviral drug valacyclovir to pregnant women could help their unborn babies who were already infected with cytomegalovirus (CMV). CMV is a leading infectious cause of lifelong neurological disabilities in newborns. Researchers gave the drug to 41 mothers to see if it could lower the amount of virus in the baby and reduce serious symptoms at birth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOETUSES INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Necker Enfants Malades
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.